Risk assessment has been the primary method to inform occupational and environmental health policy and management for many types of hazards. Although often focused on one hazard at a time, risk ...

Johns Hopkins Bloomberg School of Public Health 615 N. Wolfe Street, Baltimore, MD 21205Offices & Services Alumni Giving Calendars Careers Contact Us ...

The Admissions Office is the go-to resource for students who are interested in exploring a public health education at the Johns Hopkins Bloomberg School of Public Health. We support the School's ...

Gun Violence in the United States 2023: Examining the Gun Suicide Epidemic ...

Receiving a diagnosis of a chronic illness can be life-altering. Along with the day-to-day physical symptoms of the illness, emotions such as sadness, grief, and denial, as well as an added financial ...

Since 1991, when the CDC and the American Academy of Pediatrics recommended hepatitis B vaccination for all newborns, infections with hepatitis B virus in children and teens have decreased by 99%.

On Sunday, most of the U.S. will advance their clocks one hour for daylight saving time (DST). The change means disruptions in the sleep patterns of over 300 million people—the effects of which will ...

After the death of actor Matthew Perry, ketamine—for decades used as a popular party drug—came into the public eye once more. According to the medical examiner, Perry, who had been undergoing ...

A new report from the Bloomberg American Health Initiative at the Johns Hopkins Bloomberg School of Public Health finds that life expectancy in the United States is, on average, 78.6 years versus 81.3 ...

Harm reduction is exactly what it sounds like: reducing the harm associated with using drugs through a variety of public health interventions. But the concept relies on more than these tools and ...

As COVID-19 outbreaks continue to flare up across the U.S., the need for coronavirus testing remains urgent. Individuals rely on test results to guide their medical treatment and decisions on whether ...

In 1971, the FDA approved the measles-mumps-rubella (MMR) vaccine, which combined three vaccines that had been approved previously—in 1963, 1967, and 1969, respectively. The vaccine has proven safe ...